Adenoma Detection Rate: Insights from Bahrain Dr. Najah Al Zayyani’s Presentation

During the recent Scientific Week hosted by Dar Al Shifa Hospital – Kuwait, Bahrain Specialist Hospital was proudly represented by Dr. Najah Rashid Al Zayyani, Consultant Gastroenterologist, Founder and Vice-President of BSH, who delivered a compelling presentation on Adenoma Detection Rate (ADR) — a critical quality indicator in colonoscopy practice.

Why ADR Matters ?

Adenoma Detection Rate is widely recognized as one of the most important benchmarks in colorectal cancer prevention. Higher ADRs are directly linked to reduced incidence of colorectal cancer and improved patient outcomes. Dr. Najah emphasized that ADR is not merely a statistic — it reflects the skill, vigilance, and commitment of gastroenterologists to early detection and prevention.

Personal Experience from Bahrain

Drawing on her extensive clinical experience, Dr. Najah shared local data and personal reflections from Bahrain, highlighting:

• The challenges of implementing ADR monitoring in a regional context.
• Variability in detection rates across different patient populations.
• The importance of continuous training, technology adoption, and adherence to international guidelines.
• How cultural sensitivity and patient education play a role in encouraging screening compliance.

Her presentation underscored the need for regional benchmarking, encouraging hospitals in Bahrain and the GCC to adopt ADR as a standard measure of quality in endoscopy.

Key Takeaways from the CME:

• ADR is a cornerstone of colorectal cancer prevention and should be integrated into CME programs for gastroenterologists.
• Continuous professional development — including workshops, peer review, and case sharing — can help raise detection rates.
• Collaboration across institutions in Bahrain and the GCC will strengthen data collection and improve outcomes.
• Patient awareness campaigns are essential to increase screening uptake and ensure early detection, especially for colon cancer.

Leadership in Action

Dr. Najah’s contribution reflects BSH’s commitment to academic leadership and clinical excellence. By sharing her personal experience and advocating for ADR as a quality benchmark, she reinforces the hospital’s role as a regional leader in advancing medical standards and patient-centered care.

Closing Note

The presentation was not only a scientific highlight but also a reminder of the hospital’s mission: to combine clinical expertise with community awareness, ensuring that every patient benefits from the highest standards of preventive care.